Psoriasis Clinical Trial
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
Summary
This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 06826647) in participants with moderate to severe HS. The study will have a maximum duration of approximately 26 weeks. This includes an up to 6-week Screening Period, a 16 week Dosing Period and a 4 week Follow up Period.
Eligibility Criteria
Inclusion Criteria:
male or female participants, between 18-75, with a diagnosis of moderate to severe Hidradenitis Suppurativa
Exclusion Criteria:
History of human immunodeficiency virus (HIV) or positive HIV serology at screening,
Infected with hepatitis B or hepatitis C viruses.
Have evidence of active or latent or inadequately treated infection with Mycobacterium tuberculosis (TB)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 67 Locations for this study
Birmingham Alabama, 35233, United States
Birmingham Alabama, 35249, United States
Birmingham Alabama, 35249, United States
Birmingham Alabama, 35294, United States
Scottsdale Arizona, 85259, United States
Fremont California, 94538, United States
Long Beach California, 90806, United States
Los Angeles California, 90033, United States
San Francisco California, 94115, United States
San Francisco California, 94115, United States
San Francisco California, 94118, United States
Santa Monica California, 90404, United States
Bridgeport Connecticut, 06606, United States
Shelton Connecticut, 06484, United States
Jacksonville Florida, 32204, United States
Jacksonville Florida, 32216, United States
Largo Florida, 33770, United States
Miami Florida, 33125, United States
North Miami Beach Florida, 33162, United States
Ocala Florida, 34470, United States
Ocala Florida, 34471, United States
Ocala Florida, 34471, United States
Orange Park Florida, 32073, United States
Ormond Beach Florida, 32174, United States
Pembroke Pines Florida, 33028, United States
Tampa Florida, 33613, United States
Tampa Florida, 33615, United States
Newnan Georgia, 30263, United States
Sandy Springs Georgia, 30328, United States
Watkinsville Georgia, 30677, United States
Skokie Illinois, 60077, United States
Clarksville Indiana, 47129, United States
Indianapolis Indiana, 46250, United States
Louisville Kentucky, 40241, United States
Boston Massachusetts, 02118, United States
Boston Massachusetts, 02118, United States
Boston Massachusetts, 02215, United States
Detroit Michigan, 48202, United States
Troy Michigan, 48084, United States
Minneapolis Minnesota, 55455, United States
Minneapolis Minnesota, 55455, United States
Minneapolis Minnesota, 55455, United States
Saint Joseph Missouri, 64506, United States
Saint Louis Missouri, 63110, United States
Omaha Nebraska, 68144, United States
Henderson Nevada, 89052, United States
New York New York, 10029, United States
Tulsa Oklahoma, 74136, United States
Hershey Pennsylvania, 17033, United States
Hershey Pennsylvania, 17033, United States
Philadelphia Pennsylvania, 19103, United States
Philadelphia Pennsylvania, 19107, United States
Philadelphia Pennsylvania, 19107, United States
Humboldt Tennessee, 38343, United States
Jackson Tennessee, 38305, United States
Jackson Tennessee, 38305, United States
Arlington Texas, 76011, United States
Pflugerville Texas, 78660, United States
Murray Utah, 84107, United States
Richmond Virginia, 23298, United States
Bellevue Washington, 98004, United States
Bellevue Washington, 98004, United States
Seattle Washington, 98101, United States
Phillip Australian Capital Territory, 2606, Australia
Kogarah New South Wales, 2217, Australia
Sydney New South Wales, 2010, Australia
Woolloongabba Queensland, 4102, Australia
Carlton Victoria, 3053, Australia
East Melbourne Victoria, 3002, Australia
Barrie Ontario, L4M 7, Canada
London Ontario, N6A 2, Canada
London Ontario, N6H 5, Canada
Peterborough Ontario, K9J 5, Canada
Richmond Hill Ontario, L4B 1, Canada
Sherbrooke Quebec, J1L 0, Canada
Quebec , G1W4R, Canada
Quebec , G2J 0, Canada
How clear is this clinincal trial information?